1. Field of the Invention
The present invention relates to devices and methods of immobilizing patients for radiation therapy.
2. Description of the Related Art
Whole breast radiotherapy is a treatment that may follow local excision (lumpectomy) of invasive breast cancer. One rationale for adjuvant radiotherapy is to reduce the recurrence rate of the breast cancer by eliminating residual foci of cancer in the region of the primary tumor as well as presumed occult multicentric disease in remote areas of the breast. However, the majority of cancer recurrences in the same breast after breast radiation therapy are in the same quadrant as the initial tumor. In fact, some 80-90% of breast cancer recurrences after breast radiation therapy occur in the immediate vicinity of the lumpectomy scar. Accordingly, treatment directed more specifically at the region of the breast involved with cancer may be equally efficacious in minimizing breast recurrence.
Neither this summary nor the following detailed description purports to define the invention. The invention is defined by the claims.
In one embodiment, a method of forming a support structure for immobilizing a patient in a prone position for delivery of radiation to at least one breast of the patient comprises positioning a support brassier on the patient, the support brassier comprising a semi-rigid cup sized to engage a breast of the patient, positioning the patient in a prone position in a support structure so that the cup is proximate to, but not in contact with, a bottom surface of the support structure. The method further comprises placing a malleable substance around the cup so that the substance substantially occupies a space between the bottom surface of the support structure and the cup with the patient positioned in the support structure and hardening the malleable substance that is placed around the cup so that the malleable substance becomes a substantially rigid breast immobilization device comprising contours corresponding with the cup.
In one embodiment, a device for immobilizing a patient for delivery of radiation to a breast of the patient comprises a support structure for supporting a patient in a prone position and a breast immobilization device comprising contours that substantially define a negative relief image of a cup that is fitted over a breast of the patient, the breast immobilization device being positioned within the support structure so that the cup engages and is supported by the breast immobilization device.
In one embodiment, a method of immobilizing a patient for radiation therapy to the patient's chest comprises positioning a breast immobilization device within a support structure, the breast immobilization device comprising contours that are custom-fit to engage with at least one of a patient's breasts and positioning the patient in a prone position on the support structure so that the at least one breast engages with the contours of the support structure.
In one embodiment, a device for immobilizing a patient for delivery of radiation to a breast of the patient comprises means for supporting a patient in a prone position and means for immobilizing a breast of the patient during delivery of radiation to the breast, the immobilization means being supported by the supporting means, wherein the immobilization means is configured to reproducibly position the breast for each of a plurality of radiotherapy treatments.
Embodiments of the invention will now be described with reference to the accompanying Figures, wherein like numerals refer to like elements throughout The terminology used in the description presented herein is not intended to be interpreted in any limited or restrictive manner, simply because it is being utilized in conjunction with a detailed description of certain specific embodiments of the invention. Furthermore, embodiments of the invention may include several novel features, no single one of which is solely responsible for its desirable attributes or which is essential to practicing the inventions herein described.
In one embodiment, the radiation therapy system 100 is designed to deliver therapeutic doses of proton beams to a target area within the patient. Additional details on the structure and operation of such a proton radiation system can be found in U.S. Pat. No. 4,870,287, titled MULTI-STATION PROTON BEAM THERAPY SYSTEM, which is incorporated herein in its entirety by reference. In other embodiments, the system 100 is designed to deliver any other clinically suitable form of radiation known in the art, such as, for example, x-rays, gamma rays, hadrons, neutrons, etc.
In certain embodiments, the radiation therapy system 100 may include a patient treatment station and a gantry 102 which includes a generally hemispherical or frustoconical support frame for attachment and support of other components of the radiation therapy system 100. Additional details on the structure and operation of the gantry 102 can be found in U.S. Pat. Nos. 4,917,344 and 5,039,057, both titled ROLLER-SUPPORTED, MODULAR, ISOCENTRIC GENTRY AND METHOD OF ASSEMBLY, which are each incorporated by reference in their entireties.
The exemplary system 100 also comprises a nozzle 110 which is attached and supported by the gantry 102 such that the nozzle 110 may revolve relatively precisely about a gantry isocenter 120. The system 100 comprises a radiation source 106 delivering a therapeutic beam, such as a beam of accelerated protons, which pass through and are shaped by an aperture positioned on a distal end of the nozzle 110. An exemplary beam path is represented by numeral 146. In one embodiment, the aperture may be adjusted according to a patient's particular prescription of therapeutic radiation therapy. In other embodiments, alternative gantry configuration may be used in order to direct a radiation beam towards the patient 108.
In the embodiment of
The exemplary system 100 also comprises a patient positioner 114 and a patient support structure 130, also referred to as a pod 130, attached to the patient positioner 114. In one embodiment, the patient positioner 114 is adapted to, upon receipt of appropriate movement commands, position the patient support structure 130 in multiple translational and rotational axes and may be capable of positioning the patient support structure 130 in three orthogonal translational axes (e.g., longitudinal, vertical, and lateral) as well as three orthogonal rotational axes (e.g., pitch, roll, and yaw) so as to provide a full six degrees freedom of motion to placement of the patient support structure 130. In the illustration of
In certain embodiments, such as will be described in further detail below, an immobilization device may be positioned in the support structure 130 and shaped to interface with the contours of a specific patient's body. Thus, in the embodiment of
While the following description periodically refers to the patient positioning system 100, the improved devices and methods described herein are usable with various other patient positioning systems. For example, the devices and methods described herein are usable with other automatic, semi-automatic, manual controlled with direct interface to the positioner controller, or fully manual (e.g., releasing a brake and moving each device axis with a hand crank), positioning systems. Thus, the systems and methods discussed herein are suitable for use with any other radiotherapy treatment devices and facilities.
The radiation system 100 may be used to deliver radiation treatment to any portion of a patient, including a patient's breast or breasts. While the system 100 may be used to provide whole breast radiation to the patient, systems and methods that provide partial breast radiotherapy, thereby reducing the negative effects of radiation on the entire breast, may provide effective adjuvant radiotherapy to a cancer (or other treatment) region in a patient's breast, while minimizing recurrence of cancer in the treated breast. More particularly, by confining treatment to a limited volume of breast tissue adjacent to the treatment region of the breast, such as a lumpectomy cavity, the amount of normal tissue exposed to radiotherapy can be reduced, potentially reducing acute and chronic toxicity. In addition, the smaller target volumes may allow use of hypofractionated treatment schedules, which decrease the time and inconvenience of breast conservation therapy, possibly minimizing scheduling problems with systemic chemotherapy, and potentially improving outcome by reducing delay to local therapy. Partial-breast radiation therapy may include post-operative interstitial brachytherapy, intracavitary brachytherapy to lumpectomy cavity, and/or external beam radiotherapy with photons utilizing 3-D conformal techniques, for example, among other known or later developed techniques.
Proton therapy may possess characteristics that prove useful for performing partial breast irradiation. In comparison to three-dimensional conformal radiation therapy with x-rays, the inherently superior depth dose characteristics (Bragg peak) minimizes the integral dose delivered to surrounding normal tissues, particularly the lung, heart, chest wall and treatment breast. For example, the physical properties of proton beams allow precise beam stopping within tissue at any given depth and shape, which may allow a reduction in an integral dose delivered to normal tissues. Furthermore, this allows highly conformal doses to be delivered with a very uniform dose distribution, eliminating “hot spots” from within the treatment region. Additionally, proton therapy is non-invasive and does not require disruptions to the skin of the breast, which may lead to an improved cosmetic outcome. Accordingly, immobilization devices and methods described herein may be used in conjunction with proton therapy planning and delivery, as well as any other type of radiation planning and delivery devices.
As those of skill in the art will recognize, the level of immobilization of a patient and, more specifically, of a treatment region of the patient, is determined based at least partly on a size of the treatment region that is irradiated. For example, if a patient is completely immobilized so that there is no movement of the treatment region, irradiation may be targeted to only the treatment region without including any of the surrounding tissue in the treatment plan. Thus, an irradiation area in a partial breast treatment plan may be reduced through improved immobilization of the breast.
Depending on the patient, the breasts move from a little to a lot as the patient breaths. Accordingly, even if the treatment breast is immobilized, there is still a certain amount of movement of the breast due to movement of the patient's lungs caused by normal breathing. Accordingly, the treatment region of a breast may be further reduced if movement of the breasts can be reduced.
According to the improved systems and methods described herein, a patient may be immobilized so that a treatment breast is accurately returned to a known position for each radiotherapy treatment. Additionally, the improved systems and methods reduce respiratory movement of the breasts. Thus, the immobilization devices and techniques described herein provide accurate and reproducible breast positioning while simultaneously eliminating respiratory motion. By providing accurately repeatable breast positioning, as well as reduction in respiratory motion, the systems and methods described herein allow treatment of a reduced treatment region of the patient's breast.
In the embodiment of
In one embodiment, prior to forming the breast immobilization device 210, the patient's shoulders, abdomen, and/or pelvis are supported by pillows, beanbags, foam structures, such as foam bead vacuum cushions, and/or other support structures. In this embodiment, when the patient is properly positioned on the foam bead vacuum cushions, for example, an opening around the chest area is formed, which may be filled with two-part expandable foam, for example, in order to form the breast immobilization device 210. In one embodiment, the air may be removed from the vacuum cushions prior to placement of the two-part foam around the chest area, in order to provide a substantially rigid immobilization for the head, shoulder, abdomen, and/or pelvis areas, while leaving an open space between the breasts and the support surface 200. Thus, after formation of the immobilization device 210 around the patient's chest area, the support structure 200 is filled with one or more pillows, beanbags, or foam structures that support the legs, head, and arms of the patient while the chest area of the patient is supported by a breast immobilization device 210 comprising expandable foam, or like material. In one embodiment, the breast immobilization device 210 may be formed of one or more foam bead vacuum cushions or other materials that suitably conform to the contours of a patient's breast(s) and provide a rigid or semi-rigid support structure.
In the embodiment of
With reference again to
Beginning in block 410, a support structure having contours customized for immobilization of a particular patient is fabricated, such as according to the method of
Continuing to block 420, a treatment plan is developed for delivering radiation therapy to the patient. The radiation may be any type available for treatment, such as x-ray or proton therapy, for example. The developed treatment plan may include full breast or partial breast treatments. In one embodiment, because the breast immobilization device 210 provides reproducible immobilization of the patient's breast, the efficiency of the radiation therapy may be increased. Accordingly, use of the breast immobilization device 210 in treatment planning may reduce the time required for the actual radiation delivery to a lumpectomy, or other treatment region. In addition, the improved immobilization of the patient's breast, and the reduction of movement normally caused by breathing that is realized by placing a patient in a prone position, allows the treatment plan to reduce a target area of the breast and reduce the amount of tissue peripheral to the treatment region that receives radiation.
In certain embodiments, three-dimensional multi-beam proton treatment plans are developed. In one embodiment, the treatment plan calls for three to four separate axial treatment beams that are utilized with various beam weightings. For example, a proton beam may be utilized for treatments with appropriate apertures, compensators and beam modulation. In one embodiment, beams are chosen to provide complete sparing of underlying cardiac and pulmonary tissue as well as avoiding the breast that is not targeted for treatment. Care may also be taken to provide adequate skin sparing.
Moving to block 430, the patient is immobilized for radiation treatment, such as according to the method of
Next, in block 440, radiation therapy, such as partial breast radiation therapy, is delivered to the patient. As noted above, any other type of radiation therapy may also be administered to the patient that is immobilized by the immobilization device.
Continuing to block 450, the administering physician, radiologist, or other personnel, determines if additional doses are to be delivered to the patient. In one embodiment, this determination is made primarily based on the predetermined treatment plan and may be made prior to fabrication of the immobilization device. For example, a radiation oncologist may prescribe a particular radiation dose on a periodic basis for a predetermined time period, such as every day for 2-6 weeks or once a week for several months. In some embodiments, the effects of the treatment are monitored and the treatment plan may be adjusted after certain radiotherapy treatments. If additional doses are to be applied, the method returns to block 430 where the patient is again immobilized and irradiation is applied to the immobilized breast (block 440). In one embodiment, the patient is fitted with the support brassiere, which may be reproducibly placed on the chest by utilizing applied skin marks. The patient may then be positioned in the breast immobilization device in a prone position on the support structure. In certain embodiments, orthogonal diagnostic quality x- rays are performed prior to each treatment and compared to digitally reconstructed radiographs to reproduce the body/breast position at the time of treatment planning CT scan. In certain embodiments, clips, such as titanium clips, which are placed at the periphery of the biopsy cavity or other anatomical locations may also be utilized for the alignment process.
Advantageously, the time period between sequential radiation treatments, and the associated immobilization of the patient, may vary significantly without affecting the reproducibility of immobilization that is obtained through using the breast immobilization device, and optionally the support brassier. For example, a patient treatment plan may call for daily, weekly, or monthly treatments. In any case, the patient is reproducibly immobilized using the breast immobilization device that is contoured to support the specific patient's breast in the prone position. As noted above, because the patient is placed in the prone position, the amount of breast movement caused by breathing may also be reduced, when compared to the amount of breast movement when in a supine position.
When no further treatment sessions are necessary, the method continues to block 450 where the treatment is complete.
Beginning in block 510, the patient is fitted with a support brassier, such as the brassier illustrated in
Moving to block 520, the patient is positioned in a support structure, such as support structure 200 (
Continuing to block 530, the patient's shoulders, abdomen, and/or pelvis are supported by pillows, beanbags, foam structures, such as foam bead vacuum cushions, and/or other support structures, while leaving an area around the breasts temporarily directly unsupported. In this embodiment, the air may be removed from the vacuum cushions prior to placement of the two-part foam around the chest area (block 540), in order to provide a substantially rigid immobilization for the head, shoulder, abdomen, and/or pelvis areas. Thus, in certain embodiments the pod 200 is at least partially filled with one or more pillows, beanbags, foam structures, or similar materials. In certain embodiments, blocks 520 and 530 are performed concurrently, as the positioning of support structures around the patient aid in positioning of the patient's treatment breast in the appropriate positioned with respect to the pod 200.
Continuing to block 540, a two-part foam is poured around the chest region of the patient and allowed to harden around the breasts so that the contours of the breasts, or of the support brassier if used, are mirrored in negative relief in the hardened foam. More particularly, the two-part foam is initially malleable so that it may be poured around the chest of the patient and substantially fills the air spaces around the breasts (or brassiere). In one embodiment, the two-part form undergoes chemical changes that cause the foam to solidify. Accordingly, because the two-part form is placed around the breasts prior to solidifying, the foam will become a hardened mold of the patient's breasts, or of the support brassiere, when solidified in order to form the breast immobilization device. This breast immobilization device allows the breast to remain in a hanging position, rather than being compressed against a bottom surface of the pod 200. In one embodiment, rather than using two-part foam, the breast immobilization device may be formed of one or more foam bead vacuum cushion, or other materials that suitably conform to the contours of a patient's breast (and/or support brassiere) and provide a rigid or semi-rigid support structure.
Beginning at block 610, the support brassier that was used to fabricate the breast immobilization device is repositioned on the patient. In one embodiment, the support brassiere is reproducibly placed on the chest of the patient utilizing applied skin marks. In other embodiments, other markers, such as small tattoos, for example, may be used to position the support brassier in substantially the same position on the patient as when the breast immobilization device was fabricated.
Moving to block 620, the patient is positioned in a prone position within the pod containing the breast immobilization device. In one embodiment, the patient lays on the pod containing the breast immobilization device so that the treatment breast is placed in the corresponding countour in the immobilization device. With the patient positioned on the pod, the pod may be moved to the radiation delivery area, such as within a gantry for radiotherapy.
The foregoing description details certain embodiments of the invention. It will be appreciated, however, that no matter how detailed the foregoing appears in text, the invention can be practiced in many ways. As is also stated above, it should be noted that the use of particular terminology when describing certain features or aspects of the invention should not be taken to imply that the terminology is being re-defined herein to be restricted to including any specific characteristics of the features or aspects of the invention with which that terminology is associated. The scope of the invention should therefore be construed in accordance with the appended claims and any equivalents thereof.
Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are incorporated by reference under 37 C.F.R. §1.57 and made a part of this specification. This application is a continuation of U.S. application Ser. No. 13/540,475, filed Jul. 2, 2012, which is a continuation of U.S. application Ser. No. 12/515,523, filed May 19, 2009, issued as U.S. Pat. No. 8,210,899 on Jul. 3, 2012, which is a national phase application of International Application No. PCT/US2007/085309, filed Nov. 20, 2007, designating the United States of America and published in the English language, which claims priority under 35 U.S.C. §119(e) to U.S. Provisional Patent Application No. 60/866,814, filed Nov. 21, 2006.
Number | Name | Date | Kind |
---|---|---|---|
2469084 | Schenker | May 1949 | A |
2580264 | Wright et al. | Dec 1951 | A |
2675564 | Hughes | Apr 1954 | A |
3145240 | Proulx et al. | Aug 1964 | A |
3397411 | Rossi | Aug 1968 | A |
3449570 | Kok | Jun 1969 | A |
3545739 | D'Avignon | Dec 1970 | A |
3556455 | Storm | Jan 1971 | A |
3604931 | Kastner et al. | Sep 1971 | A |
3640787 | Heller | Feb 1972 | A |
3689949 | Weinstein et al. | Sep 1972 | A |
3707734 | Matthews | Jan 1973 | A |
3745998 | Rose | Jul 1973 | A |
3762404 | Sakita | Oct 1973 | A |
3778049 | Viamonte, Jr. | Dec 1973 | A |
3783251 | Pavkovich | Jan 1974 | A |
3848132 | Foderaro | Nov 1974 | A |
3851644 | Slagle | Dec 1974 | A |
3852610 | McIntyre | Dec 1974 | A |
3885258 | Regan | May 1975 | A |
3893198 | Blair | Jul 1975 | A |
3897345 | Foster | Jul 1975 | A |
3897777 | Morrison | Aug 1975 | A |
3901588 | Longhenry | Aug 1975 | A |
3905054 | Windsor et al. | Sep 1975 | A |
3942012 | Boux | Mar 1976 | A |
3947686 | Cooper et al. | Mar 1976 | A |
3957262 | McReynolds | May 1976 | A |
3986697 | Amor, Jr. et al. | Oct 1976 | A |
4030719 | Gabriele et al. | Jun 1977 | A |
4034224 | Heavens et al. | Jul 1977 | A |
4045830 | Loeb et al. | Sep 1977 | A |
4064401 | Marden | Dec 1977 | A |
4069457 | Martin et al. | Jan 1978 | A |
4095114 | Taumann | Jun 1978 | A |
4112306 | Nunan | Sep 1978 | A |
4140129 | Heinz et al. | Feb 1979 | A |
4146793 | Bergstrom et al. | Mar 1979 | A |
4190772 | Dinwiddie et al. | Feb 1980 | A |
4206355 | Boux | Jun 1980 | A |
4230129 | LeVeen | Oct 1980 | A |
4250137 | Riedler | Feb 1981 | A |
4252594 | Cooper | Feb 1981 | A |
4256112 | Kopf et al. | Mar 1981 | A |
4262204 | Mirabella | Apr 1981 | A |
4269512 | Nosler | May 1981 | A |
4287425 | Elliott, Jr. | Sep 1981 | A |
4327046 | Davis et al. | Apr 1982 | A |
4347213 | Rogers, Jr. | Aug 1982 | A |
4378813 | Lovelace et al. | Apr 1983 | A |
4392239 | Wilkens | Jul 1983 | A |
4400820 | O'Dell et al. | Aug 1983 | A |
4401492 | Pfrommer | Aug 1983 | A |
4442352 | Brahme | Apr 1984 | A |
4450122 | Gallina | May 1984 | A |
4484571 | Velazquez | Nov 1984 | A |
4504050 | Osborne | Mar 1985 | A |
4552508 | Reid | Nov 1985 | A |
4578757 | Stark | Mar 1986 | A |
4591341 | Andrews | May 1986 | A |
4600551 | Erb | Jul 1986 | A |
4616814 | Harwood-Nash et al. | Oct 1986 | A |
4628523 | Heflin | Dec 1986 | A |
4666304 | Davies | May 1987 | A |
4671284 | Wilson et al. | Jun 1987 | A |
4672212 | Brahme | Jun 1987 | A |
4682818 | Morell | Jul 1987 | A |
4688780 | Hanz | Aug 1987 | A |
4705955 | Mileikowsky | Nov 1987 | A |
4752064 | Voss | Jun 1988 | A |
4779858 | Saussereau | Oct 1988 | A |
4789930 | Sones et al. | Dec 1988 | A |
4796613 | Heumann et al. | Jan 1989 | A |
4812658 | Koehler | Mar 1989 | A |
4815448 | Mills | Mar 1989 | A |
4819257 | Grasser et al. | Apr 1989 | A |
4841965 | Jacobs | Jun 1989 | A |
4848340 | Bille et al. | Jul 1989 | A |
4870287 | Cole et al. | Sep 1989 | A |
4905267 | Miller et al. | Feb 1990 | A |
4907251 | Mork et al. | Mar 1990 | A |
4912787 | Bradcovich | Apr 1990 | A |
4917344 | Prechter et al. | Apr 1990 | A |
4926457 | Poehner et al. | May 1990 | A |
4979519 | Chavarria et al. | Dec 1990 | A |
5014290 | Moore et al. | May 1991 | A |
5017789 | Young et al. | May 1991 | A |
5037374 | Carol | Aug 1991 | A |
5039057 | Prechter et al. | Aug 1991 | A |
5039867 | Nishihara et al. | Aug 1991 | A |
5046708 | Schaefer | Sep 1991 | A |
5048071 | Van Steenburg | Sep 1991 | A |
5049147 | Danon | Sep 1991 | A |
5054049 | Manabe | Oct 1991 | A |
5079426 | Antonuk et al. | Jan 1992 | A |
5081665 | Kostich | Jan 1992 | A |
5090047 | Angotti et al. | Feb 1992 | A |
5094241 | Allen | Mar 1992 | A |
5107839 | Houdek et al. | Apr 1992 | A |
5117829 | Miller et al. | Jun 1992 | A |
5156166 | Sebring | Oct 1992 | A |
5168514 | Horton, Jr. et al. | Dec 1992 | A |
5207688 | Carol | May 1993 | A |
5240218 | Dye | Aug 1993 | A |
5242455 | Skeens et al. | Sep 1993 | A |
5269305 | Corol | Dec 1993 | A |
5274864 | Morgan | Jan 1994 | A |
5276927 | Day | Jan 1994 | A |
5278886 | Kobiki et al. | Jan 1994 | A |
5281232 | Hamilton et al. | Jan 1994 | A |
5287576 | Fraser | Feb 1994 | A |
5343048 | Pastyr | Aug 1994 | A |
5361765 | Herlihy et al. | Nov 1994 | A |
5370117 | McLaurin, Jr. | Dec 1994 | A |
5370118 | Vij et al. | Dec 1994 | A |
5380336 | Misko et al. | Jan 1995 | A |
5382914 | Hamm et al. | Jan 1995 | A |
5388580 | Sullivan et al. | Feb 1995 | A |
5402463 | Umetani et al. | Mar 1995 | A |
5427097 | Depp | Jun 1995 | A |
5446548 | Gerig et al. | Aug 1995 | A |
5454993 | Kostich | Oct 1995 | A |
5464411 | Schulte et al. | Nov 1995 | A |
5485502 | Hinton | Jan 1996 | A |
5485833 | Dietz | Jan 1996 | A |
5511549 | Legg et al. | Apr 1996 | A |
5531229 | Dean et al. | Jul 1996 | A |
5538494 | Matsuda | Jul 1996 | A |
5549616 | Schulte | Aug 1996 | A |
5566681 | Manwaring | Oct 1996 | A |
5570409 | Yamaguchi et al. | Oct 1996 | A |
5588430 | Bova et al. | Dec 1996 | A |
5595191 | Kirk | Jan 1997 | A |
5596619 | Carol | Jan 1997 | A |
5602892 | Llacer | Feb 1997 | A |
5622187 | Carol | Apr 1997 | A |
5675851 | Feathers | Oct 1997 | A |
5676673 | Ferre et al. | Oct 1997 | A |
5727554 | Kalend et al. | Mar 1998 | A |
5730745 | Schulte et al. | Mar 1998 | A |
5745545 | Hughes | Apr 1998 | A |
5751781 | Brown et al. | May 1998 | A |
5769779 | Alderson | Jun 1998 | A |
5771512 | Kurakake et al. | Jun 1998 | A |
5775337 | Hauger et al. | Jul 1998 | A |
5778047 | Mansfield et al. | Jul 1998 | A |
5782244 | Kostich | Jul 1998 | A |
5792147 | Evans et al. | Aug 1998 | A |
5797924 | Schulte | Aug 1998 | A |
5800352 | Ferre et al. | Sep 1998 | A |
5806116 | Oliver et al. | Sep 1998 | A |
5820444 | McGaughey | Oct 1998 | A |
5820553 | Hughes | Oct 1998 | A |
5823192 | Kalend et al. | Oct 1998 | A |
5825845 | Blair et al. | Oct 1998 | A |
5832550 | Hauger et al. | Nov 1998 | A |
5847403 | Hughes et al. | Dec 1998 | A |
5848449 | Hauger et al. | Dec 1998 | A |
5851182 | Sahadevan | Dec 1998 | A |
5865832 | Knopp et al. | Feb 1999 | A |
5895926 | Britton et al. | Apr 1999 | A |
5911655 | Brenneisen | Jun 1999 | A |
5947981 | Cosman | Sep 1999 | A |
5983424 | Näslund | Nov 1999 | A |
6003174 | Kantrowitz | Dec 1999 | A |
6023694 | Kouchi et al. | Feb 2000 | A |
6026392 | Kouchi et al. | Feb 2000 | A |
6085227 | Edlund et al. | Jul 2000 | A |
6094760 | Nonaka et al. | Aug 2000 | A |
6104779 | Shepherd et al. | Aug 2000 | A |
6118848 | Reiffel | Sep 2000 | A |
6161237 | Tang et al. | Dec 2000 | A |
6178430 | Cohen et al. | Jan 2001 | B1 |
6195578 | Distler et al. | Feb 2001 | B1 |
6240161 | Siochi | May 2001 | B1 |
6269499 | Amir | Aug 2001 | B1 |
6275564 | Ein-Gal | Aug 2001 | B1 |
6279579 | Riaziat et al. | Aug 2001 | B1 |
6282739 | Livingston | Sep 2001 | B1 |
6308353 | Van Steenburg | Oct 2001 | B1 |
6316776 | Hiramoto et al. | Nov 2001 | B1 |
6325758 | Carol et al. | Dec 2001 | B1 |
6345114 | Mackie et al. | Feb 2002 | B1 |
6355049 | Gill | Mar 2002 | B1 |
6375355 | Fortin | Apr 2002 | B1 |
6376846 | Livingston | Apr 2002 | B2 |
6385286 | Fitchard et al. | May 2002 | B1 |
6405072 | Cosman | Jun 2002 | B1 |
6437513 | Stelzer et al. | Aug 2002 | B1 |
6445766 | Whitham | Sep 2002 | B1 |
6446286 | Karmalawy | Sep 2002 | B1 |
6452999 | Maida | Sep 2002 | B1 |
6462490 | Matsuda et al. | Oct 2002 | B1 |
6462553 | Badura | Oct 2002 | B1 |
6466813 | Shukla et al. | Oct 2002 | B1 |
6473490 | Siochi | Oct 2002 | B1 |
6476403 | Dolinskii et al. | Nov 2002 | B1 |
6565577 | Cosman | May 2003 | B2 |
6577707 | Siochi | Jun 2003 | B2 |
6597005 | Badura et al. | Jul 2003 | B1 |
6598275 | Kolody et al. | Jul 2003 | B1 |
6600164 | Badura et al. | Jul 2003 | B1 |
6614038 | Brand et al. | Sep 2003 | B1 |
6621889 | Mostafavi | Sep 2003 | B1 |
6639234 | Badura et al. | Oct 2003 | B1 |
6650930 | Ding | Nov 2003 | B2 |
6662036 | Cosman | Dec 2003 | B2 |
6665555 | Henderson | Dec 2003 | B2 |
6670618 | Hartmann et al. | Dec 2003 | B1 |
6677597 | Haberer et al. | Jan 2004 | B1 |
6683318 | Haberer et al. | Jan 2004 | B1 |
6690965 | Riaziat et al. | Feb 2004 | B1 |
6693283 | Eickhoff et al. | Feb 2004 | B2 |
6698045 | Coppens et al. | Mar 2004 | B1 |
6704957 | Rhodes | Mar 2004 | B2 |
6710362 | Kraft et al. | Mar 2004 | B2 |
6725078 | Bucholz et al. | Apr 2004 | B2 |
6730921 | Kraft | May 2004 | B2 |
6731970 | Schlossbauer et al. | May 2004 | B2 |
6736831 | Hartmann et al. | May 2004 | B1 |
6745072 | Badura et al. | Jun 2004 | B1 |
6754299 | Patch | Jun 2004 | B2 |
6757355 | Siochi | Jun 2004 | B1 |
6769806 | Moyers | Aug 2004 | B2 |
6774383 | Norimine et al. | Aug 2004 | B2 |
6777700 | Yanagisawa et al. | Aug 2004 | B2 |
6780149 | Schulte | Aug 2004 | B1 |
6792078 | Kato et al. | Sep 2004 | B2 |
6795523 | Steinberg | Sep 2004 | B2 |
6799068 | Hartmann et al. | Sep 2004 | B1 |
6803591 | Yamashita et al. | Oct 2004 | B2 |
6804548 | Takahashi et al. | Oct 2004 | B2 |
6809325 | Dahl et al. | Oct 2004 | B2 |
6813788 | Dinkler et al. | Nov 2004 | B2 |
6814694 | Pedroni | Nov 2004 | B1 |
6839404 | Clark et al. | Jan 2005 | B2 |
6855942 | Bechthold et al. | Feb 2005 | B2 |
6859741 | Haberer et al. | Feb 2005 | B2 |
6865411 | Erbel et al. | Mar 2005 | B2 |
6891177 | Kraft et al. | May 2005 | B1 |
6904630 | Al-Kassim et al. | Jun 2005 | B2 |
7011447 | Moyers | Mar 2006 | B2 |
7063461 | Coppens et al. | Jun 2006 | B2 |
7073508 | Moyers | Jul 2006 | B2 |
7076821 | DeMooy | Jul 2006 | B2 |
7120223 | Nafstadius | Oct 2006 | B2 |
7142634 | Engler et al. | Nov 2006 | B2 |
7154108 | Tadokoro et al. | Dec 2006 | B2 |
7154991 | Earnst et al. | Dec 2006 | B2 |
7173265 | Miller et al. | Feb 2007 | B2 |
7199382 | Rigney et al. | Apr 2007 | B2 |
7280633 | Cheng et al. | Oct 2007 | B2 |
7290548 | Ungemach et al. | Nov 2007 | B2 |
7301162 | Matsuda et al. | Nov 2007 | B2 |
7331713 | Moyers | Feb 2008 | B2 |
7348579 | Pedroni | Mar 2008 | B2 |
7372053 | Yamashita et al. | May 2008 | B2 |
7398309 | Baumann et al. | Jul 2008 | B2 |
7446328 | Rigney et al. | Nov 2008 | B2 |
7582886 | Trbojevic | Sep 2009 | B2 |
7587024 | Grözinger et al. | Sep 2009 | B2 |
7589334 | Hiramoto et al. | Sep 2009 | B2 |
7659521 | Pedroni | Feb 2010 | B2 |
7753587 | Kusch et al. | Jul 2010 | B2 |
7796730 | Marash et al. | Sep 2010 | B2 |
7847275 | Lifshitz et al. | Dec 2010 | B2 |
7984715 | Moyers | Jul 2011 | B2 |
7997553 | Sloan et al. | Aug 2011 | B2 |
8003964 | Stark et al. | Aug 2011 | B2 |
8083408 | Moyers | Dec 2011 | B2 |
8093569 | Miller et al. | Jan 2012 | B2 |
8100132 | Markstroem | Jan 2012 | B2 |
8129699 | Balakin | Mar 2012 | B2 |
8160205 | Saracen et al. | Apr 2012 | B2 |
8210899 | Bush | Jul 2012 | B2 |
8373143 | Balakin | Feb 2013 | B2 |
8418288 | Miller et al. | Apr 2013 | B2 |
8479743 | Moyers | Jul 2013 | B2 |
8523630 | Bush | Sep 2013 | B2 |
8567405 | Arn et al. | Oct 2013 | B2 |
8688197 | Balakin | Apr 2014 | B2 |
20020027969 | Maida | Mar 2002 | A1 |
20020051513 | Pugachev et al. | May 2002 | A1 |
20020065461 | Cosman | May 2002 | A1 |
20020077545 | Takahashi et al. | Jun 2002 | A1 |
20020188194 | Cosman | Dec 2002 | A1 |
20020193685 | Mate et al. | Dec 2002 | A1 |
20030007601 | Jaffray et al. | Jan 2003 | A1 |
20030031301 | Longton et al. | Feb 2003 | A1 |
20030086527 | Speiser et al. | May 2003 | A1 |
20030095625 | Steinberg | May 2003 | A1 |
20030164459 | Schardt et al. | Sep 2003 | A1 |
20030183779 | Norimine et al. | Oct 2003 | A1 |
20040013414 | Karger et al. | Jan 2004 | A1 |
20040028188 | Amann et al. | Feb 2004 | A1 |
20040034438 | Uematsu | Feb 2004 | A1 |
20040034932 | Zacharopoulos | Feb 2004 | A1 |
20040042583 | Wackerle et al. | Mar 2004 | A1 |
20040082856 | Marmarelis | Apr 2004 | A1 |
20040098804 | Varadharajulu et al. | May 2004 | A1 |
20040136495 | Carlsson et al. | Jul 2004 | A1 |
20040155206 | Marchand et al. | Aug 2004 | A1 |
20040158145 | Ghelmansarai et al. | Aug 2004 | A1 |
20040174958 | Moriyama et al. | Sep 2004 | A1 |
20040184579 | Mihara et al. | Sep 2004 | A1 |
20040184583 | Nagamine et al. | Sep 2004 | A1 |
20050116175 | Haberer | Jun 2005 | A1 |
20060002511 | Miller et al. | Jan 2006 | A1 |
20060183960 | Sioshansi et al. | Aug 2006 | A1 |
20070093100 | Sommer | Apr 2007 | A1 |
20080005643 | Park et al. | Jan 2008 | A1 |
20080031414 | Coppens | Feb 2008 | A1 |
20080042076 | Miller et al. | Feb 2008 | A1 |
20080187097 | Cheng et al. | Aug 2008 | A1 |
20080192892 | Dilmanian et al. | Aug 2008 | A1 |
20090067577 | Rigney et al. | Mar 2009 | A1 |
20090154645 | Lifshitz et al. | Jun 2009 | A1 |
20090168960 | Jongen et al. | Jul 2009 | A1 |
20090202045 | Guertin et al. | Aug 2009 | A1 |
20090217456 | Lempen et al. | Sep 2009 | A1 |
20090260636 | Markstroem | Oct 2009 | A1 |
20090304153 | Amelia et al. | Dec 2009 | A1 |
20090309046 | Balakin | Dec 2009 | A1 |
20090314960 | Balakin | Dec 2009 | A1 |
20100162488 | Dahlin et al. | Jul 2010 | A1 |
20110185503 | Yan | Aug 2011 | A1 |
20120143051 | Balakin | Jun 2012 | A1 |
Number | Date | Country |
---|---|---|
2 513 896 | Oct 1975 | DE |
2 833 800 | Dec 1979 | DE |
4 418 216 | Nov 1995 | DE |
196 12 091 | Mar 1997 | DE |
102 48 476 | Sep 2003 | DE |
0 019 136 | Nov 1980 | EP |
0 247 449 | Dec 1987 | EP |
0 283 082 | Sep 1988 | EP |
0 465 590 | Jan 1992 | EP |
0 986 070 | Mar 2000 | EP |
0 986 071 | Mar 2000 | EP |
1 064 881 | Jan 2001 | EP |
1 454 653 | Sep 2004 | EP |
1 584 353 | Oct 2005 | EP |
1 709 994 | Jan 2006 | EP |
1 792 595 | Jun 2007 | EP |
1 795 229 | Jun 2007 | EP |
1 900 392 | Mar 2008 | EP |
1 935 453 | Jun 2008 | EP |
2 368 600 | Sep 2011 | EP |
1 660 175 | Feb 2012 | EP |
2 701 391 | Aug 1994 | FR |
0 870 225 | Jun 1961 | GB |
2 068 700 | Aug 1981 | GB |
2 213 066 | Aug 1989 | GB |
58-92905 | Jun 1983 | JP |
58-152541 | Sep 1983 | JP |
60-73506 | May 1985 | JP |
61-194400 | Aug 1986 | JP |
07-204184 | Aug 1995 | JP |
7-299059 | Nov 1995 | JP |
7309246 | Oct 1974 | NL |
WO 8801848 | Mar 1988 | WO |
WO 9011721 | Oct 1990 | WO |
WO 9011723 | Oct 1990 | WO |
WO 9408704 | Apr 1994 | WO |
WO 9508293 | Mar 1995 | WO |
WO 9910137 | Mar 1999 | WO |
WO 0016175 | Mar 2000 | WO |
WO 0059575 | Oct 2000 | WO |
WO 0100276 | Jan 2001 | WO |
WO 0189625 | Nov 2001 | WO |
WO 0263638 | Feb 2002 | WO |
WO 03039212 | May 2003 | WO |
WO 03053520 | Jul 2003 | WO |
WO 03076016 | Sep 2003 | WO |
WO 2004026401 | Apr 2004 | WO |
WO 2004032781 | Apr 2004 | WO |
WO 2005018734 | Mar 2005 | WO |
WO 2005018735 | Mar 2005 | WO |
WO 2005037167 | Apr 2005 | WO |
WO 2005102453 | Nov 2005 | WO |
WO 2006060886 | Jun 2006 | WO |
WO 2006076545 | Jul 2006 | WO |
WO 2006094533 | Sep 2006 | WO |
WO 2007054140 | May 2007 | WO |
WO 2007061426 | May 2007 | WO |
WO 2007062788 | Jun 2007 | WO |
WO 2007068066 | Jun 2007 | WO |
WO 2007127970 | Nov 2007 | WO |
WO 2008051358 | May 2008 | WO |
WO 2008064271 | May 2008 | WO |
WO 2008081480 | Jul 2008 | WO |
WO 2008142695 | Nov 2008 | WO |
WO 2009129847 | Oct 2009 | WO |
WO 2009142544 | Nov 2009 | WO |
WO 2009142545 | Nov 2009 | WO |
WO 2009142546 | Nov 2009 | WO |
WO 2009142548 | Nov 2009 | WO |
WO 2009142549 | Nov 2009 | WO |
WO 2010078048 | Jul 2010 | WO |
WO 2011094674 | Aug 2011 | WO |
Entry |
---|
Baglan, et al., “The Use of High-Dose-Rate Brachytherapy Alone After Lumpectomy in Patients With Early- Stage Breast Cancer Treated With Breast-Conserving Therapy” Int. J. Radiation Oncology Biol. Phys., vol. 50, No. 4, pp. 1003-1011, 2001. |
Baglan, et al.: “Accelerated Partial Breast Irradiation Using 3D Conformal Radiation Therapy (3D-CRT)”, n. Engl.J.Med., vol. 55, No. 2, pp. 302-311, 2003. |
Crile et al., “Factors Influencing Local Recurrence of Cancer After Partial Mastectomy” Cleveland Clinic Journal of Medicine, vol. 57, No. 2, pp. 143-146, Mar.-Apr. 1990. |
Dedicated Medical Ion Accelerator Design Study by Lawrence Berkeley Laboratory. et al., Dec. / 1977, PCTA008295-PCTA008455. |
Design of a Proton Therapy Synchrotron by Fermi National Accelerator Laboratory. Jun. 1986, LL467-LL574. |
Extended European Search Report for EP Application No. 07871543.0, mailed on May 4, 2012 in 9 pages. |
Fisher, et al., “Twenty-Year Follow-Up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy Plus Irradiation for the Treatment of Invasive Breast Cancer” N Engl. J. Med., vol. 347, No. 16, pp. 1233-1241, Oct. 17, 2002. |
Fisher, et al., “Conservative Surgery for the Management of Invasive and Noninvasive Carcinoma of the Breast: NSABP Trials” World J. Surg. 18, pp. 63-69, 1994. |
Fisher, et al., “Pathologic Findings from the National Surgical Adjuvant Breast Project (Protocol 6)” A Journal of American Cancer Society, vol. 57, No. 9, pp. 1717-1724, May 1, 1986. |
Formenti, et al., “T1 Stage Breast Cancer: Adjuvant Hypofractionated Conformal Radiation Therapy to Tumor Bed in Selected Postmenopausal Breast Cancer Patients-Pilot Feasibility Study” Radiation Oncology, vol. 222, No. 1, pp. 172-178, Jan. 2002. |
King, et al., “Long-Term Results of Wide-Field Brachytherapy as the Sole Method of Radiation Therapy after Segmental Mastectomy for Tis,1,2 Breast Cancer” The American Journal of Surgery, vol. 180, pp. 299-304, Oct. 2000. |
Krishnan, et al., “Breast Conservation Therapy With Tumor Bed Irradiation Alone With a Selected Group of Patients With Stage I Breast Cancer” The Breast Journal, vol. 7, No. 2, pp. 91-96, 2001. |
Liljegren, et al., “Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: Five-Year Results of a Randomized Triall” Journal of the National Cancer Institute, vol. 86, No. 9, pp. 717-722, May 4, 1994. |
Miller, Daniel W. “Review of Proton Beam Radiation Therapy” Medical Physics, vol. 22, No. 11, Pt. 2, pp. 1943-1954, Nov. 1995. |
Perera, et al. “Method of Localization and Implantation of the Lumpectomy Site for High Dose Rate Brachytherapy after Conservative Surgery for T1 and T2 Breast Cancer” Int. J. Radiation Oncology Biol. Phys., vol. 31, No. 4, pp. 959-965, 1995. |
Perera, et al. “Local Resection and Brachytherapy Connected to the Lumpectomy Site for Early Breast Cancer: A Pilot Study” Journal of Surgical Oncology, vol. 65, No. 4, pp. 263-268, Aug. 1997. |
Polgar, et al. “Sole Brachytherapy of the Tumor Bed After Conservative Surgery for T1 Breast Cancer: Five-Year Results of a Phase I-II Study and Initial Findings of a Randomized Phase III Trial” Journal of Surgical Oncology, vol. 80, Issue 3, pp. 121-128, Jul. 2002. |
Poti, et al., “Partial Breast Irradiation With Interstitial60 Co Brachytherapy Results in Frequent Grade 3 or 4 Toxicity. Evidence Based on a 12-Year Follow-Up of 70 Patients” Int. J. Radiation Oncology Biol. Phys., vol. 58, No. 4, pp. 1022-1033, 2004. |
Proton Therapy System by Brobeck Corporation, Nov. 1985, LL54413-LL54459. |
Schmidt-Ullrich, et al. “Breast Conservation Therapy for Early Stage Breast Carcinoma With Outstanding 10-Year Locoregional Control Rates: A Case for Aggressive Therapy to the Tumor Bearing Quadran” Int. J. Radiation Oncology Biol. Phys., vol. 27, pp. 545-552, ran Int. J. Radiation Oncology Biol. Phys., vol. 27, pp. 545-552, 1993. |
Urano, et al., “Ralative Biological Effectiveness of Modulated Proton Beams in Various Murine Tissues” Int. J. Radiation Oncology Biol. Phys., vol. 10, No. 4, pp. 509-514, 1984. |
Vaidya, et al. “Targeted Intra-Operative Radiotherapy (Targit): An Innovative Method of Treatment for Early Breast Cancer” Annals of Oncology, vol. 12, pp. 1075-1080, 2001. |
Veronesi, et al. “A Preliminary Report of Intraoperative Radiotherapy (IORT) in Limited-Stage Breast Cancers that are Conservatively Treated” European Journal of Cancer 37, pp. 2178-2183, 2001. |
Veronesi, et al. “Twenty-Year Follow-Up of a Randomized Study Comparing Breast-Conserving Surgery With Radical Mastectomy for Early Breast Cancer” N. Engl. J. Med., vol. 347, No. 16, pp. 1227-1232, Oct. 17, 2002. |
Vicini, et al. “Accelerated Treatment of Breast Cancer” Journal of Clinical Oncology, vol. 19, No. 7, pp. 1993-2001, Apr. 1, 2001. |
Wazer, et al., “Preliminary Results of a Phase I/II Study of HDR Brachytherapy Alone for T1/T2 Breast Cancer” Int. J. Radiation Oncology Biol. Phys., vol. 50, No. 4, pp. 889-897, 2002. |
Wazer, et al., “Clinically Evident Fat Necrosis in Women Treated With High-Dose-Rate Brachytherapy Alone for Early-Stage Breast Cancer” Int. J. Radiation Oncology Biol. Phys., vol. 50, No. 1, pp. 107-111, 2001. |
Whelan, et al. “Ipsilateral Breast Tumor Recurrence Postlumpectomy is Predictive of Subsequent Mortality: Results from a Randomized Trial” Int. J. Radiation Oncology Biol. Phys., vol. 30, pp. 11-16, 1994. |
Alpha Cradle, advertisement by Smithers Medical Products, Inc., received by Applicants in 1988. |
Bush, David: “A Technique of Partial Breast Irradiation Utilizing Proton Beam Radiotherapy Comparison with Conformal X-Ray Therapy,” Cancer Journal, Mar./Apr. 2007, vol. 13, Issue 2, pp. 114-118. |
Clark, et al.: “A Halo-ring Technique for Fractionated Stereotactic Radiotherapy”, The British Journal of Radiology, 1996, 66, 522-527. |
Hamilton, Russel J.: “Repositioning Accuracy of Non-Invasive Head Fixation System for Stereotectic Radiotherapy” MED-PHYS.23 (11). Nov. 1969, p. 1909-1917, XP000680957. |
Metcalfe et al., “Patient Immobiliation and Image Guidance,” The Physics of Radiotherapy X-Rays and Electrons, Capter 12: 2007, p. 727-764. |
Proceedings of a Medical Workshop on Accelerators for Charged-Particle Beam Therapy by Fermilab, Jan. 1985, LL33170-LL33313. |
Gill, et al.: “Relocatable Frame for Stereotactic External Beam Radiotherapy”, Int. J. Radiation Oncology, Biol. Phys. vol. 20, pp. 599-603, Mar. 1991. |
CBI Product Overview, CP-100 Robot Patient Positioner (www.bioinstruments.net/cp-100), color brochure downloaded from www.bioinstruments.net/cp-100 on Feb. 13, 2015, corresponding to brochure available for download as early as Aug. 2007. |
Number | Date | Country | |
---|---|---|---|
20140217634 A1 | Aug 2014 | US |
Number | Date | Country | |
---|---|---|---|
60866814 | Nov 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13540475 | Jul 2012 | US |
Child | 14015002 | US | |
Parent | 12515523 | US | |
Child | 13540475 | US |